StockData
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. (BIAFW) stock

BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)

Close on Oct 30, 2026Market cap $23.58MP/E –Yield –

bioAffinity Technologies EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

bioAffinity Technologies's EPS for the twelve months ending Sep 30, 2025 was -$20.62. For fiscal 2025 it was -$8.66.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.66–
FY2024Dec 31, 2024-$22.50–
FY2023Dec 31, 2023-$27.30–
FY2022Dec 31, 2022-$54.30–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.64–
Q1 FY2026Mar 31, 2026-$0.81–
Q3 FY2025Sep 30, 2025-$4.74–
Q2 FY2025Jun 30, 2025-$5.07–
Q1 FY2025Mar 31, 2025-$4.80–
Q4 FY2024Dec 31, 2024-$6.01–
Q3 FY2024Sep 30, 2024-$4.84–
Q2 FY2024Jun 30, 2024-$5.70–
Q1 FY2024Mar 31, 2024-$6.00–
Q4 FY2023Dec 31, 2023-$7.63–
Q3 FY2023Sep 30, 2023-$7.80–
Q2 FY2023Jun 30, 2023-$6.00–
Q1 FY2023Mar 31, 2023-$5.40–
Q4 FY2022Dec 31, 2022-$5.97–
Q3 FY2022Sep 30, 2022-$35.10–
Q2 FY2022Jun 30, 2022-$0.90–
Q1 FY2022Mar 31, 2022-$16.47–
Q4 FY2021Dec 31, 2021-$62.51–
Q3 FY2021Sep 30, 2021-$16.98–

More bioAffinity Technologies figures